 |
Top 6 Crohn’s Disease treatment startups
Updated: May 09, 2024 | Editor: Jason Kwon |
Crohn's Disease treatment startups are focused on developing innovative technologies, such as biologics, nanomedicine, and targeted drug delivery systems, to provide more effective therapies and personalized treatment options for individuals with Crohn's Disease.
1
Country: China | Funding: $195M
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
2
Country: France | Funding: €175.8M
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system.
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system.
3
Country: USA | Funding: $70M
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.
4
Country: USA | Funding: $8.3M
DNAlite Therapeutics committed to bringing the next-generation of drugs to organs protected by mucus barriers. Diseases such as FAP, colorectal cancer, and Crohn's disease are currently treated with complete or partial removal of the colon and/or rectum. Our aim is to prevent, rather than manage the progression of these diseases.
DNAlite Therapeutics committed to bringing the next-generation of drugs to organs protected by mucus barriers. Diseases such as FAP, colorectal cancer, and Crohn's disease are currently treated with complete or partial removal of the colon and/or rectum. Our aim is to prevent, rather than manage the progression of these diseases.
5
Country: USA | Funding: $2.2M
SmartTab is a digital medicine company which develops innovative wireless drug delivery and monitoring systems.
SmartTab is a digital medicine company which develops innovative wireless drug delivery and monitoring systems.
6
Country: Israel | Funding: $100K
Exosomm develops food solutions based on natural milk exosomes. Exosomm’s first product is a food formula with a patented-based active anti-inflammatory effect designed for patients with inflammatory bowel diseases (Crohn´s & Colitis).
Exosomm develops food solutions based on natural milk exosomes. Exosomm’s first product is a food formula with a patented-based active anti-inflammatory effect designed for patients with inflammatory bowel diseases (Crohn´s & Colitis).
